Прогепар Drug photo

The description is actual on 19.11.2014

  • Latin name: Prohepar
  • ATH code: A05BA
  • Active ingredient: Inositol (Inositol), Extract of a liver of KPC N (Extractum Hepatis KPC N), Cyanocobalamine (Cyanocobalamin)
  • Producer: NORDMARK ARZNEIMITTEL, GmbH & Co.KG (Germany)


This means has in structure cyanocobalamine, inositol and extract of a liver KPC N which contains sincaline hydrotartrate, cysteine a hydrochloride and cysteine.

Release form

Means contains in bottles. Rolled into one there can be 20, 50 or 100 tablets.

Pharmacological action

Gepatoprotektor of a natural origin.

Pharmacodynamics and pharmacokinetics

Drug keeps and recovers structure of hepatocytes, promotes recovery of a parenchyma, interferes with formation of connecting fabric. Besides, it helps with normalization of a local blood-groove in hepatic fabric, improves functions of a liver and increases diuresis.

This means actually is a hydrolyzate of a liver of young bulls (till 6 months) who had a special diet. Animals are grown up in a special way and pass obligatory veterinary control.

In their liver there are useful amino acids, microelements, nucleosides and other substances which are well influencing an organism.

Drug is a source of necessary chrome. He also delivers to hepatic cells the necessary substances which promote that hepatocytes carried out the functions.

Indications to Progepar's use

Indications to Progepar's (Prohepar) use following:

  • need of complex treatment at chronic hepatitis;
  • toxic hepatitises;
  • hepatopathies of various origin;
  • radial illness;
  • psoriasis;
  • fatty dystrophy of a liver of various origin;
  • cirrhosis;
  • medicinal poisoning;
  • need of carrying out course of treatment cytostatics.


Medicine cannot be applied at hypersensitivity to its components, and also at children's age.

Side effects

The producer informs that at the use of drug allergic reactions are possible.

Application instruction of Progepar (Way and dosage)

The scheme of reception of tablets needs to be agreed with the doctor. For those to whom appointed Progepar the application instruction reports that a usual day dosage – 3-6 tablets. It + is divided into three equal receptions. The application instruction of Progepar recommends to swallow them entirely, washing down with liquid and not chewing. Duration of therapy is defined individually.


Data on overdose are not available.


About clinically significant interaction of medicine with other means it is not reported.

Terms of sale

Medicine is sold according to the recipe.

Storage conditions

Optimum temperature of medicine is up to 25 °C. It is necessary to keep this means in the dry, unavailable to children and well protected from sunshine place.

Period of validity

Three years.

Progepar's analogs

Structural analogs of Progepar are not made.

Similar drugs on pharmacological group:

About Progepare

About Progepare in the majority positive. Patients note undoubted efficiency of drug. Comments of doctors on Progepare also generally laudatory. Many call the only shortcoming the high price of this means. Nevertheless, most of the patients leaving About Progepare agree that such expenditure of money is justified. They note among positive characteristics and the fact that medicine is made on a natural basis. It causes trust as in the beginning it was carefully tested abroad, and only then came to domestic drugstores.


  • Progepar of 400 mg No. 50 of a tablet p/onordmark Arznaymittel GMBH and To. KG
  • Progepar of 400 mg No. 100 of a tablet p/onordmark Arznaymittel GMBH and To. KG

Drugstore of IFC

  • Progepar tab p / about No. 50, Nordmark Arzneimittelgermaniya
to show still


  • Progepar of the tab. No. 100farma Interneshenal (Jordan)
  • Progepar of the tab. No. 50farma Interneshenal (Jordan)
Section: For a liver
PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Progepar surely consult with the attending physician.